Form 4: Amgen EVP & CFO Peter H. Griffith Reports Stock Disposal

Peter H. Griffith, EVP & CFO of Amgen Inc., reported the disposal of 648 shares of common stock on May 5, 2024, to cover tax obligations related to vested Restricted Stock Units (RSUs).

Summary

• On May 5, 2024, Peter H. Griffith, the EVP & CFO of Amgen Inc., disposed of 648 shares of Amgen's common stock.
• The transaction was executed at a price of $311.29 per share.
• The disposal was related to the satisfaction of tax obligations arising from the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Griffith directly owns 32,777 shares of Amgen common stock, which includes vested and unvested RSUs and dividend equivalents.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives. This filing indicates the sale of shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine sale of shares by an executive for tax purposes.

Key Dates